Drugs, risk and society: Government, governance or governmentality?

Health, Risk and Society

Volumn 13, Issue 5, 2011, Pages 389-396

  Alaszewski, Andy ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COCAINE; GOLDSHIELD; ILLICIT DRUG; LEVOTHYROXINE SODIUM; NON PRESCRIPTION DRUG; THALIDOMIDE; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTHRALGIA; COMMON COLD; DEPRESSION; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG MISUSE; DRUG USE; EDITORIAL; GOVERNMENT; HEALTH HAZARD; HUMAN; HYPOTHYROIDISM; MYALGIA; NEW ZEALAND; PRESCRIPTION; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER;

EID: 79961142689     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698575.2011.601579     Document Type: Editorial

References (15)

1. Abraham, J., 2002. A social science framework for the analysis of health technology regulation: The risks and benefits of innovative pharmaceuticals in a comparative context. Health, Risk & Society, 4 (3), 305-324.
2. Alaszewski, A. and Brown, P., 2012. Making health policy: A critical introduction. Cambridge: Polity Press. In Press.
3. Bissell, P., May, C.R., and Noyce, P.R., 2004. From compliance to concordance: Barriers to accomplishing a re-framed model of health care interactions. Social science & medicine, 58 (4), 851-862.
4. Davis, C. and Abraham, J., 2011. A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation. Health, Risk & Society, 13 (5), this issue.
5. Gardener, J.G. and Drew, K., 2011. The Eltroxin controversy: Risk, and how actors construct their world. Health, Risk & Society, 13 (5), this issue.
6. Harrison, L., et al., 2011. 'I don't know anyone that has two drinks a day': Young people, alcohol and the government of pleasure. Health, Risk & Society, 13 (5), this issue.
7. Himmelstein, M., et al., 2011. Over-the-counter cough and cold medicines for children: A comparison of UK and US parents' parental usage, perception and trust in governmental health organisation. Health, Risk & Society, 13 (5), this issue.
8. Hood, C., et al., 1999. Explaining risk regulation regimes: Exploring the 'minimal feasible response' hypothesis. Health, Risk & Society, 1 (2), 151-166.
9. Jin, C., et al., 2011. Framing a global health risk from the bottom-up: User perceptions and practices around antibiotics in four villages in China. Health, Risk & Society, 13 (5), this issue.
10. Lyng, S., 1990. Edgework: A social psychological analysis of voluntary risk taking. American Journal of Sociology, 95 (4), 851-886.
11. McGovern, R. and McGovern, W., 2011. Voluntary risk-taking and heavy-end crack cocaine use: An edgework perspective. Health, Risk & Society, 13 (5), this issue.
12. Moran, M., 2003. The British regulatory state: High modernism and hyper-innovation. Oxford: Oxford University Press.
13. Osimani, B., 2010. Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management. Health, Risk & Society, 12 (5), 453-469.
14. Petersen, A., 1997. Risk, governance and the new public health. In: A. Petersen and R. Bunton, eds. Foucault, health and medicine. London: Routledge, 189-204.
15. Yi-Mak, K. and Harrison, L., 2001. Globalisation, cultural change and the modern drug epidemics: The case of Hong Kong. Health, Risk & Society, 3 (1), 39-57.